Evolution of cellular inflammatory pattern in induced sputum in patients with mild-moderate asthma for five years Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population. Source: International Congress 2019 – Airway diseases and blood cells Year: 2019
Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011
The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019
A treatment regime based on induced sputum eosinophilia does not result in a reduction in exacerbations in refractory severe asthmatics Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity Year: 2008
Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Microbiological and inflammatory patterns in severe exacerbated COPD Source: Eur Respir J 2003; 22: Suppl. 45, 352s Year: 2003
The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics Source: Annual Congress 2007 - Towards controlling severe asthma Year: 2007
Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients Year: 2009
Induced sputum cell profiles in mild to severe stable asthmatics and healthy adults Source: Eur Respir J 2001; 18: Suppl. 33, 429s Year: 2001
Markers of severity and inflammatory profile during exacerbations of severe asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017
Increased sputum B cells in severe eosinophilic asthma: a local auto-inflammatory process Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics Year: 2018
Sputum microbiota in moderate versus severe patients with COPD Source: Eur Respir J 2014; 43: 1787-1790 Year: 2014
Surrogate markers of airway inflammation are not increased in actively smoking mild to moderate asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 283s Year: 2001
Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
Role of neutrophils in airway inflammation in children with severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010